drugset / Trial / NCT00222105
A Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of Life
NaSingle-groupOpen-labelTreatment
Summary
Four monthly treatments with pegylated liposomal doxorubicin, thalidomide and dexamethasone for newly diagnosed myeloma patients as induction therapy prior to high dose chemotherapy and autologous stem cell transplant.
Timeline
- Start
- 2002-11
- Primary completion
- 2009-04
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | 40 mg | — |
| Subject | Doxorubicin | Other / unclassified | 40 mg/m2 | Intravenous |
| Subject | Thalidomide | Other / unclassified | 50 mg | — |
| Subject | Thalidomide | Other / unclassified | 100 mg | — |